Home » Topics » Briefs » Other news to note

Other news to note
RSS

Mallinckrodt completes acquisition of InfaCare Pharmaceutical

Sep. 26, 2017

EpiVax launches precision immunotherapy venture

Sep. 26, 2017

Disarm Therapeutics announces USD 30 million series A financing

Sep. 22, 2017

Pendopharm invests in Edesa Biotech and licenses three anorectal treatments

Sep. 21, 2017

LifeMine Therapeutics closes series A financing

Sep. 21, 2017

Acer Therapeutics completes merger with Opexa Therapeutics

Sep. 20, 2017

Ultragenyx proposes to acquire Dimension Therapeutics

Sep. 20, 2017

Arrowhead updates status of pipeline

Sep. 19, 2017

Moderna Therapeutics reports new development candidates and pipeline progress

Sep. 19, 2017

Pain Therapeutics receives NIH grants to support Alzheimer's and pain programs

Sep. 19, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...